Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study.

Rutten FH, Moons KG, Cramer MJ, Grobbee DE, Zuithoff NP, Lammers JW, Hoes AW.

BMJ. 2005 Dec 10;331(7529):1379. Epub 2005 Dec 1.

2.

Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.

Tung RH, Camargo CA Jr, Krauser D, Anwaruddin S, Baggish A, Chen A, Januzzi JL Jr.

Ann Emerg Med. 2006 Jul;48(1):66-74. Epub 2006 Feb 17.

PMID:
16781921
3.

The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure.

Kelder JC, Cramer MJ, van Wijngaarden J, van Tooren R, Mosterd A, Moons KG, Lammers JW, Cowie MR, Grobbee DE, Hoes AW.

Circulation. 2011 Dec 20;124(25):2865-73. doi: 10.1161/CIRCULATIONAHA.111.019216. Epub 2011 Nov 21.

4.

Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care.

Verdú JM, Comín-Colet J, Domingo M, Lupón J, Gómez M, Molina L, Casacuberta JM, Muñoz MA, Mena A, Bruguera-Cortada J.

Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):613-9. doi: 10.1016/j.recesp.2012.01.019. Epub 2012 Apr 26. English, Spanish.

PMID:
22541282
5.

Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease.

Grasso S, Leone A, De Michele M, Anaclerio R, Cafarelli A, Ancona G, Stripoli T, Bruno F, Pugliese P, Dambrosio M, Dalfino L, Di Serio F, Fiore T.

Crit Care Med. 2007 Jan;35(1):96-105.

PMID:
17095948
7.

N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.

Ouanes I, Jalloul F, Ayed S, Dachraoui F, Ouanes-Besbes L, Fekih Hassen M, Elatrous S, Abroug F.

Respirology. 2012 May;17(4):660-6. doi: 10.1111/j.1440-1843.2012.02153.x.

PMID:
22348741
8.

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.

J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. Epub 2007 Oct 29.

9.

Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease.

Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, Hoes AW.

Eur Heart J. 2005 Sep;26(18):1887-94. Epub 2005 Apr 28.

10.

Cardiovascular magnetic resonance imaging to identify left-sided chronic heart failure in stable patients with chronic obstructive pulmonary disease.

Rutten FH, Vonken EJ, Cramer MJ, Moons KG, Velthuis BB, Prakken NH, Lammers JW, Grobbee DE, Mali WP, Hoes AW.

Am Heart J. 2008 Sep;156(3):506-12. doi: 10.1016/j.ahj.2008.04.021. Epub 2008 Jun 17.

PMID:
18760133
11.

Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.

Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL Jr.

J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. Epub 2005 Dec 9.

12.

[Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].

El Mahmoud R, Alibay Y, Brun-Ney D, Boulard JC, Dubourg O, Puy H, Jondeau G.

Arch Mal Coeur Vaiss. 2006 Mar;99(3):201-7. French.

PMID:
16618022
13.

Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure.

Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt P.

J Card Fail. 2005 Jun;11(5 Suppl):S15-20.

PMID:
15948095
14.

Utility of N terminal pro brain natriuretic peptide in elderly patients.

Sivakumar R, Wellsted D, Parker K, Lynch M, Ghosh P, Khan SA.

Postgrad Med J. 2006 Mar;82(965):220-3.

15.

[Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure].

Wang F, Li W, Huang J, Wang L, Bian WY, Pang HM, Wang Y, Xu ZM, Li YS.

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Jan;34(1):28-32. Chinese.

PMID:
16626545
16.

Value of brain natriuretic peptides in primary care patients with the clinical diagnosis of chronic heart failure.

Zuber M, Cuculi F, Attenhofer Jost CH, Kipfer P, Buser P, Seifert B, Erne P.

Scand Cardiovasc J. 2009;43(5):324-9. doi: 10.1080/14017430902769919.

PMID:
19247872
17.

Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.

Behnes M, Brueckmann M, Ahmad-Nejad P, Lang S, Wolpert C, Elmas E, Kaelsch T, Gruettner J, Weiss C, Borggrefe M, Neumaier M.

Int J Cardiol. 2009 Jun 26;135(2):165-74. doi: 10.1016/j.ijcard.2008.03.045. Epub 2008 Jul 7.

PMID:
18603317
18.
19.

Strategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): a cluster randomized trial.

van Riet EE, Hoes AW, Limburg A, van der Hoeven H, Landman MA, Rutten FH.

BMC Cardiovasc Disord. 2014 Jan 8;14:1. doi: 10.1186/1471-2261-14-1.

20.

Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests.

Oudejans I, Mosterd A, Bloemen JA, Valk MJ, van Velzen E, Wielders JP, Zuithoff NP, Rutten FH, Hoes AW.

Eur J Heart Fail. 2011 May;13(5):518-27. doi: 10.1093/eurjhf/hfr021. Epub 2011 Mar 19.

Items per page

Supplemental Content

Write to the Help Desk